Lise Munsie

Lise Munsie currently serves as Vice President of Process Development at BlueRock Therapeutics, overseeing the development of PSC-derived cell therapy programs aimed at patient accessibility. Additionally, Lise is a Director on the Board of the Huntington Society of Canada, contributing to efforts that support individuals and families affected by Huntington's Disease. Previously, Lise held leadership roles at CCRM, including Vice President of the iPSC Technology Platform and Director of Process and Analytical Development, where responsibilities included advancing allogeneic iPSC therapies and managing a team focused on cell and gene therapy development. Lise's early career includes a postdoctoral fellowship at The University of British Columbia, specializing in the genetics of Parkinson's Disease. Lise holds a PhD in Biochemistry and Biomedical Science from McMaster University and a B.Sc. in Molecular Biology and Genetics from the University of Guelph.